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Abstract
Osseous metaplasia has recently been described in several cases of nephrogenic systemic fibrosis, sometimes in
association with unusual clinical features such as painful hyperkeratotic spicules, palpable bony masses, and
disease regression. Some authors have suggested that it may mainly occur late in the disease course or even be
a marker for involuting nephrogenic systemic fibrosis. Here, we present a 27-year-old woman with a 7-year history
of nephrogenic systemic fibrosis, who developed cutaneous osseous metaplasia.
Introduction
Recently, several reports of patients with nephrogenic systemic fibrosis (NSF) and histological evidence of
cutaneous [1-3] or extracutaneous [4, 5] osseous metaplasia have appeared in the literature. The significance of
this rare histological finding remains uncertain. Clinically, the development of osseous metaplasia in NSF has been
correlated with various findings, such as new painful hyperkeratotic spicules [1], palpable bony masses [5], and
softening of previously indurated plaques [1]. However, several other cases have apparently not demonstrated any
obviously unusual clinical features [3]. Some authors have suggested that osseous metaplasia primarily develops
in longstanding lesions of NSF late in the course of the disease [1, 2, 5] or may even be a marker for involuting or
resolving NSF [1, 2]. Cases of osseous metaplasia in NSF have demonstrated histological features reminiscent of
NSF (e.g., increased and thickened collagen, spindle cells, stromal mucin, sparse inflammatory infiltrate), as well
as islands and spicules of variably mineralized woven bone, often containing fragmented elastic fibers. Variable
features include calcification (sparing vasculature), osteoblasts, osteoclasts, “elastocollagenous balls” [2], and
transepidermal elimination [1]. Histologically, osseous metaplasia in NSF should be distinguished from collagenous
sclerotic bodies with entrapped elastic fibers, another recently reported rare finding in NSF [6]. As in other
examples of secondary osteoma cutis, the pathogenesis of osseous metaplasia in NSF remains uncertain.
Here, we present a 27-year-old woman with systemic lupus erythematosus, nephritis, dialysis-dependent renal
failure, and a 7-year history of NSF who was found to have osseous metaplasia in those biopsies taken late but
not early in the course of her disease. This case further supports the notion that osseous metaplasia tends to
mainly occur later in the course of disease, many years after clinical onset of NSF. However, the presentation and
several years of follow-up of the present case do not support the idea that osseous metaplasia is a marker of
involuting NSF or necessarily correlates with unusual clinical features.
Case report
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Figure 1A Figure 1B
Figures 1A and 1B. Punch biopsies from the arms at initial presentation demonstrating a
dermal interstitial process with minimal mononuclear inflammatory component, increased
spindled stromal cells, increased collagen, and increased mucin (H&E, x4, x20).
A 20-year-old Caucasian woman with a history of systemic lupus erythematosus complicated by chronic renal
insufficiency secondary to diffuse proliferative glomerulonephritis, presented with a new onset of skin thickening on
the arms and legs. Additional past medical history included pseudotumor cerebri, malignant hypertension, deep
venous thrombosis, avascular necrosis of the knee, osteomyelitis of the foot, seizures, irritable bowel syndrome,
depression, polysubstance abuse, hyperlipidemia, and hypothyroidism. Physical examination revealed
skin-colored indurated plaques on the arms and legs. Punch biopsies from both arms (Figure 1) revealed a dermal
interstitial process with a minimal mononuclear inflammatory component demonstrated by a paucity of staining for
CD45. Vimentin staining revealed a diffuse increase in spindled stromal cells presumably representing fibroblasts,
with few if any histiocytes in the dermis as indicated by CD68 immunostaining. Colloidal iron staining revealed
markedly increased dermal mucin. Direct immunofluorescence showed a linear granular pattern of deposition of
IgG and C3 in the basement membrane zone, representing her systemic lupus erythematosus. The differential
diagnosis at the time included scleromyxedema and interstitial granuloma annulare. Later that year, after
publication of the first descriptions of the condition then known as nephrogenic fibrosing dermopathy [7], she was
correctly diagnosed with NSF. Therapeutic trials with plaquenil and quinacrine were unsuccessful. Over the next 6
years, her renal disease worsened, requiring hemodialysis and ultimately a matched living-related kidney
transplantation. Her NSF plaques remained generally stable. Six months after transplantation, she presented
again to the dermatology service, this time because of concern about a drug eruption. She had a 1-week history of
a new red pruritic rash on her legs, which began 2 days after starting pregabalin. Physical examination revealed
skin-colored indurated plaques on the extremities and a few scattered erythematous papules on the legs. Within
the indurated plaques, there were whitish-yellow, firm, angulated nodules with a positive “tent sign” as seen with
pilomatricomas. There were no joint contractures.
Figure 2A Figure 2B
Figures 2A, 2B, and 2C. Punch biopsies from the legs upon re-presenting 6 years later to
the dermatology service, demonstrate mild dermal fibrosis, increased number of
fibroblasts, and increased dermal mucin. In the superficial and mid-dermis, there were
round collections of eosinophilic material surrounded by flattened osteoblasts and
fibrosis. (H&E, x4, x10, x20)
Because of the atypical clinical appearance and the interval change in the clinical appearance, 2 punch biopsies
(Figure 2) were taken from nodular areas on the right leg. They demonstrate mild dermal fibrosis with increased
number of fibroblasts and increased dermal mucin, consistent with NSF. In addition, there are multiple small, round
collections of eosinophilic material with surrounding fibrosis in the superficial and mid dermis, consistent with
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Figure 2C
are unremarkable. CD31 staining shows that the surrounding cells to be
negative and confirms the extravascular location of the osteomas. There
are short hyphae-like material within the osteomas, and Verhoeff-Van
Gieson stain demonstrates that they are positive-stained elastic fibers. Von
Kossa stain shows no apparent calcium deposition.
Figure 2D Figure 2E
Figure 2D. Within the osteomas, there are short hyphae-like, strands which are
consistent with elastic fibers by Verhoeff-Van Gieson stain. (x20)
Figure 2E. CD31 staining shows that the surrounding cells are negative and confirms the
extravascular location of the osteomas. (x40)
Figure 3A Figure 3B
Figures 3A and 3B. Clinical appearance 7 years after initial presentation, demonstrating
indurated plaques, minimal erythema, and whitish-yellow, firm, angulated nodules on the
arms and legs.
Her superimposed drug eruption resolving after discontinuing pregabalin. A subsequent 6-month trial of
thalidomide did not improve her NSF. At follow-up 2 years later, her lesions have not significantly changed
(Figure 3).
Discussion
Osteoma cutis is a rare phenomenon of uncertain pathogenesis characterized by the presence of mature
osseous tissue in the dermis and/or subcutis. Osteoma cutis has traditionally been divided into primary and
secondary forms (Table 1).[8, 9, 10] Secondary osteoma cutis is more common (approximately 75% of cases)
than primary osteoma cutis, more common in females, and may be associated with various inflammatory,
neoplastic, or traumatic processes, especially processes also prone to calcification. Benign neoplasms, such
as melanocytic nevi and pilomatricomas, may be the most commonly associated processes. Among the
inflammatory processes complicated by osteoma cutis are several connective tissue diseases including
scleroderma and dermatomyositis. The clinical presentation of osteoma cutis is variable and dependent upon
the type and extent of the condition, but may include local pain and disfigurement. Evaluation of patients with
t ti h ld i l d id ti f d l i i t d d i l di hi t f
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enhanced MR imaging studies. Determination of serum calcium and phosphate may help to rule out an
underyling metabolic abnormality. Serum parathyroid hormone level, vitamin D level, and 24-hour urinary
calcium excretion may also be helpful. Treatment is frequently unsatisfactory and recurrence is common.
Depending upon the type, extent, and symptoms, excision, dermabrasion, or topical retinoids may be
therapeutic options.
Nephrogenic systemic fibrosis is a recently recognized [11] systemic disorder occurring primarily in patients
with renal failure and usually with a history of receiving gadolinium-containing MR contrast agents [12].
Clinically, patients develop scleroderma-like cutaneous induration, which is typically progressive, often
painful, worse on the extremities, sparing of the face, and associated with hyperpigmentation and
contractures. Histologically, NSF closely resembles scleromyxedema, with increased collagen deposition, a
spindle cell proliferation, and increased interstitial mucin. However, findings often involve the entire dermis
and affect the subcutis, whereas scleromyxedema may be more limited to the upper and mid-dermis.
Spindle cells include dual procollagen and CD34-positive cells. Other features include a sparse
inflammatory infiltrate, increased elastic fibers, multinucleate giant cells, and dystrophic calcification. Rare
histological features can include osteoclast-like giant cells [13], elastolysis [14], calciphylaxis-like vascular
calcification [15], and pseudoxanthoma elasticum-like calcified fragmented elastic fibers [16].
Recently, cutaneous osseous metaplasia in NSF has been described in 3 reports describing a total of 4
patients (Table 2) [1, 2, 3]. This phenomenon was first reported by Ruiz-Genao et al. in 2005, in a
44-year-old man who clinically presented with painful, hyperkeratotic spicules in his popliteal fossae, which
began 5 months after the onset of his NSF. Interestingly, the spicules appeared very shortly after the
induration of his NSF spontaneously resolved. Biopsies revealed islands and spicules of variably
mineralized woven bone in the superificial dermis, containing fragmented elastic fibers and located both
parallel to and perforating the epidermal surface. Surrounding osteoblasts and osteoclasts were present.
Concomitant histological findings more typical of NSF, including fibrosis, vascular proliferation, and a
lympho-plasmacytic infiltrate were also demonstrated. Earlier biopsies of the indurated plaques, which
preceded the clinical spicules, showed more classical findings of NSF, including a proliferation of
CD34-positive fibroblast-like cells, interstitial mucin, and thick collagen bundles.
The subsequent 2 reports [2, 3] of osseous metaplasia in NSF did not include the painful hyperkeratotic
spicules or perforating epidermal changes of the patient of Ruiz-Genao et al. First, Wiedemeyer et al. [2]
described a 56-year-old man with hypertension, angiotensin converting enzyme inhibitor usage, focal
glomerulosclerosis, dialysis-dependent renal failure, and an 8-year history of NSF manifesting blotchy
red-brown macules and patches on the extremities. Biopsy of early lesions showed typical histologic
features of NSF (increased collagen, CD34+ procollagen I+ spindle cells, and mucin), whereas biopsy of
longstanding lesions showed scar-like fibrosis, refractile elastic fibers surrounded by course collagen
strands (forming structures referred to as “elastocollagenous balls”), and osseous metaplasia in the
superficial dermis, with more classical findings of NSF in the deep dermis and subcutaneous septae. On
scanning electron microscopy with energy-dispersive x-ray spectroscopy, gadolinium was undetectable in
the areas of elastocollagenous balls and osseous metaplasia but present in the deeper and/or more classic
histological areas of NSF. The authors [2] hypothesized that the elastocollagenous balls and osseous
metaplasia “may represent a late, involuting stage of NSF.” Finally, Deng et al. [3] presented 2 patients with
NSF and cutaneous osseous metaplasia, including a 51-year-old woman with dialysis-dependent renal
failure due to hypertension and a 2-year history of NSF and a 20-year-old woman with hepatic-renal
syndrome and a 2-month history of NSF. Clinically, both patients had typical findings of NSF, including
pigmented plaques on the extremities with variable pruritus, induration, and limitation of motion.
Histologically, both patients demonstrated extensive dermal calcification and islands and spicules of
mineralized and unmineralized woven bone in the upper and mid-dermis, without osteoblasts, osteoclasts,
or vascular calcification. No subsequent evaluations were provided for the patients of either Wiedemeyer et
al. or Deng et al.
Several reports of extracutaneous osseous metaplasia in patients with NSF have been published [4, 5].
Krous et al. [4] described a 15-year-old boy with a history of renal lymphoma, Ewing sarcoma, dialysis-
dependent renal failure, NSF, headaches, and seizures, whose post-mortem findings included diffuse dural
fibrosis and osseous metaplasia. Nagai et al. [5] described a 50-year-old man with an 8-year history of NSF
who presented with severe disabling joint contractures and newly palpable bony masses over his legs.
Biopsy of a large indurated nodule revealed dermal changes of NSF including increased and thickened
collagen fibers with CD34-positive plump spindle cells. The fascial layer was thickened and fibrotic, with
underlying osseous metaplasia and degenerated muscle fibers Attempts at treatment with psoralen + UVA
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and sodium thiosulphate were unsuccessful.
Osseous metaplasia in NSF can closely resemble sclerotic bodies, a rare recently reported histological
feature of NSF [6]. Bhawan et al. described 2 cases of NSF, which demonstrated dermal sclerotic bodies
with entrapped elastic fibers in the dermis. The sclerotic bodies were thought to represent calcified
hyalinized collagen. The authors highlighted this feature as a novel diagnostic clue for NSF. Like
osseous metaplasia, the sclerotic bodies contained entrapped elastic fibers. Unlike osseous metaplasia,
the sclerotic bodies lacked lacunae or cells, were more irregular in size and shape, and stained blue not
red on Masson trichrome stain.
Further reports are needed to clarify the pathogenesis and significance of osseous metaplasia in NSF.
In summary, cases of osseous metaplasia previously reported, including the present case, suggest that
it may occur late in the course of NSF and may appear in the skin or extracutaneous tissue in patients
with either typical or atypical clinical features (e.g., hyperkeratotic spicules, bony masses, whitish
nodules) for NSF.
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